• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
STOP gene Phactr4 is a tumor suppressor.STOP 基因 Phactr4 是一种肿瘤抑制基因。
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):E407-14. doi: 10.1073/pnas.1221385110. Epub 2013 Jan 14.
2
Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis.表观遗传重编程调控人乳腺上皮细胞分化、癌变和转移过程中 EcSOD 的表达。
Oncogene. 2014 Jan 16;33(3):358-68. doi: 10.1038/onc.2012.582. Epub 2013 Jan 14.
3
PHACTR4 regulates proliferation, migration and invasion of human hepatocellular carcinoma by inhibiting IL-6/Stat3 pathway.PHACTR4通过抑制IL-6/Stat3信号通路调控人肝癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2016 Aug;20(16):3392-9.
4
STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.STAT3 通过 PTEN 和 CYLD 激活 miR-21 和 miR-181b-1,是将炎症与癌症联系起来的表观遗传开关的一部分。
Mol Cell. 2010 Aug 27;39(4):493-506. doi: 10.1016/j.molcel.2010.07.023.
5
Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.共济失调毛细血管扩张突变基因(ATM)抑制可改变人乳腺上皮细胞。
J Biol Chem. 2010 Apr 23;285(17):13092-106. doi: 10.1074/jbc.M109.078360. Epub 2010 Feb 22.
6
Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.重编程雌激素反应转录组有助于 p53 缺失的乳腺上皮细胞中他莫昔芬依赖的肿瘤发生保护。
PLoS One. 2018 Mar 28;13(3):e0194913. doi: 10.1371/journal.pone.0194913. eCollection 2018.
7
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.p130Cas作为乳腺上皮细胞增殖、存活及HER2-neu癌基因依赖性乳腺肿瘤发生的新型调节因子。
Cancer Res. 2006 May 1;66(9):4672-80. doi: 10.1158/0008-5472.CAN-05-2909.
8
p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.p12(CDK2-AP1)抑制乳腺癌细胞增殖和体内肿瘤生长。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2085-93. doi: 10.1007/s00432-012-1286-z. Epub 2012 Jul 25.
9
Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.三叶因子 1(TFF1)缺乏会增加人类乳腺癌细胞的致瘤性,并会促进 TFF1 敲除小鼠的乳腺肿瘤发展。
Oncogene. 2011 Jul 21;30(29):3261-73. doi: 10.1038/onc.2011.41. Epub 2011 Feb 28.
10
DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.DLC-1基因抑制人乳腺癌细胞生长及体内致瘤性。
Oncogene. 2003 Jan 23;22(3):445-50. doi: 10.1038/sj.onc.1206064.

引用本文的文献

1
Phactr4 influences macrophage lamellipodial structure and dynamics through Arp2/3 complex and Ezrin regulation.Phactr4通过调节Arp2/3复合物和埃兹蛋白来影响巨噬细胞片状伪足的结构和动力学。
bioRxiv. 2025 May 14:2025.05.13.653717. doi: 10.1101/2025.05.13.653717.
2
FactVAE: a factorized variational autoencoder for single-cell multi-omics data integration analysis.FactVAE:用于单细胞多组学数据整合分析的因子分解变分自编码器。
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf157.
3
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.一种由生态位驱动的机制决定了髓系恶性肿瘤的反应以及一种不依赖于突变的治疗方法。
Cancer Cell. 2025 Jun 9;43(6):1007-1024.e13. doi: 10.1016/j.ccell.2025.03.007. Epub 2025 Mar 27.
4
Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia.深度基因组特征分析揭示了儿科急性髓细胞白血病的复杂性和预后标志物。
Commun Biol. 2023 Mar 31;6(1):356. doi: 10.1038/s42003-023-04732-2.
5
A Missense Variation in Associates with Impaired Actin Dynamics, Dilated Cardiomyopathy, and Left Ventricular Non-Compaction in Humans.一个错义变异与人类的肌动蛋白动力学受损、扩张型心肌病和左心室致密化不全相关。
Int J Mol Sci. 2023 Jan 10;24(2):1388. doi: 10.3390/ijms24021388.
6
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling.EROS 是一种选择性伴侣蛋白,调节吞噬细胞 NADPH 氧化酶和嘌呤能信号转导。
Elife. 2022 Nov 24;11:e76387. doi: 10.7554/eLife.76387.
7
TMED2 binding restricts SMO to the ER and Golgi compartments.TMED2 结合将 SMO 限制在 ER 和高尔基体区室中。
PLoS Biol. 2022 Mar 30;20(3):e3001596. doi: 10.1371/journal.pbio.3001596. eCollection 2022 Mar.
8
Disruption of TFIIH activities generates a stress gene expression response and reveals possible new targets against cancer.TFIIH 活性的破坏会引发应激基因表达反应,并揭示出可能针对癌症的新靶点。
Open Biol. 2020 Jun;10(6):200050. doi: 10.1098/rsob.200050. Epub 2020 Jun 17.
9
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus.抑癌基因 PNRC1 通过将脱帽复合物募集到核仁来阻断 rRNA 成熟。
EMBO J. 2018 Dec 3;37(23). doi: 10.15252/embj.201899179. Epub 2018 Oct 29.
10
Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.组合 RNA 测序分析揭示 ADAR1 在胃癌中双重调控基因的模式。
Dig Dis Sci. 2018 Jul;63(7):1835-1850. doi: 10.1007/s10620-018-5081-9. Epub 2018 Apr 25.

本文引用的文献

1
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
2
Recurrent hemizygous deletions in cancers may optimize proliferative potential.在癌症中,反复出现的半合子缺失可能会优化增殖潜能。
Science. 2012 Jul 6;337(6090):104-9. doi: 10.1126/science.1219580. Epub 2012 May 24.
3
Phactr4 regulates directional migration of enteric neural crest through PP1, integrin signaling, and cofilin activity.Phactr4 通过 PP1、整合素信号和丝切蛋白活性调节肠神经嵴的定向迁移。
Genes Dev. 2012 Jan 1;26(1):69-81. doi: 10.1101/gad.179283.111.
4
PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse.磷酸化位点数据库:一个综合性资源,用于研究人和鼠中实验确定的翻译后修饰的结构和功能。
Nucleic Acids Res. 2012 Jan;40(Database issue):D261-70. doi: 10.1093/nar/gkr1122. Epub 2011 Dec 1.
5
A continuum model for tumour suppression.肿瘤抑制的连续统模型。
Nature. 2011 Aug 10;476(7359):163-9. doi: 10.1038/nature10275.
6
Cyclin D as a therapeutic target in cancer.细胞周期蛋白 D 作为癌症治疗靶点。
Nat Rev Cancer. 2011 Jul 7;11(8):558-72. doi: 10.1038/nrc3090.
7
Making sense of cancer genomic data.解析癌症基因组数据。
Genes Dev. 2011 Mar 15;25(6):534-55. doi: 10.1101/gad.2017311.
8
Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.乳腺癌中多个原癌基因酪氨酸激酶的激活是通过 PTPN12 磷酸酶的缺失实现的。
Cell. 2011 Mar 4;144(5):703-18. doi: 10.1016/j.cell.2011.02.003.
9
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.用于体外和体内诱导性 RNA 干扰的 pINDUCER 慢病毒工具包。
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9.
10
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.COSMIC:在癌症体细胞突变目录中挖掘完整的癌症基因组。
Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50. doi: 10.1093/nar/gkq929. Epub 2010 Oct 15.

STOP 基因 Phactr4 是一种肿瘤抑制基因。

STOP gene Phactr4 is a tumor suppressor.

机构信息

Department of Genetics, Harvard University Medical School, Boston, MA 02115, USA.

出版信息

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):E407-14. doi: 10.1073/pnas.1221385110. Epub 2013 Jan 14.

DOI:10.1073/pnas.1221385110
PMID:23319639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3562831/
Abstract

Cancer develops through genetic and epigenetic alterations that allow unrestrained proliferation and increased survival. Using a genetic RNAi screen, we previously identified hundreds of suppressors of tumorigenesis and/or proliferation (STOP) genes that restrain normal cell proliferation. Our STOP gene set was significantly enriched for known and putative tumor suppressor genes. Here, we report a tumor-suppressive role for one STOP gene, phosphatase and actin regulator 4 (PHACTR4). Phactr4 is one of four members of the largely uncharacterized Phactr family of protein phosphatase 1 (PP1)-and actin-binding proteins. Our work suggests that Phactr4 restrains normal cell proliferation and transformation. Depletion of Phactr4 with multiple shRNAs leads to increased proliferation and soft agar colony formation. Phactr4 acts, in part, through an Rb-dependent pathway, because Rb phosphorylation is maintained upon growth factor withdrawal in Phactr4-depleted cells. Examination of tumor copy number analysis and sequencing revealed that PHACTR4 is significantly deleted and mutant in many tumor subtypes. Furthermore,cancer cell lines with reduced Phactr4 expression exhibit tumor suppressor hypersensitivity upon Phactr4 complementation,leading to reduced proliferation, transformation, and tumor formation. Thus, Phactr4 acts as a tumor suppressor that is deleted and mutant in several cancers.

摘要

癌症是通过遗传和表观遗传改变发展而来的,这些改变允许不受限制的增殖和增加的存活。我们之前使用遗传 RNAi 筛选,鉴定了数百个抑制肿瘤发生和/或增殖的(STOP)基因,这些基因抑制正常细胞增殖。我们的 STOP 基因集显著富集了已知和假定的肿瘤抑制基因。在这里,我们报告了一个 STOP 基因,磷酸酶和肌动蛋白调节剂 4(PHACTR4)的肿瘤抑制作用。Phactr4 是未充分表征的 Phactr 家族蛋白磷酸酶 1(PP1)和肌动蛋白结合蛋白的四个成员之一。我们的工作表明 Phactr4 抑制正常细胞增殖和转化。用多个 shRNA 耗尽 Phactr4 会导致增殖增加和软琼脂集落形成。Phactr4 部分通过 Rb 依赖性途径起作用,因为在 Phactr4 耗尽的细胞中,Rb 磷酸化在生长因子撤出后得以维持。对肿瘤拷贝数分析和测序的检查表明,在许多肿瘤亚型中,PHACTR4 缺失和突变显著。此外,表达减少的 Phactr4 的癌细胞系在 Phactr4 互补时表现出肿瘤抑制敏感性,导致增殖、转化和肿瘤形成减少。因此,Phactr4 作为一个肿瘤抑制基因,在几种癌症中缺失和突变。